These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33476681)

  • 1. Dextran sulphate inhibits an association of prions with plasma membrane at the early phase of infection.
    Fuse T; Nakagaki T; Homma T; Tange H; Yamaguchi N; Atarashi R; Ishibashi D; Nishida N
    Neurosci Res; 2021 Oct; 171():34-40. PubMed ID: 33476681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prion Protein Devoid of the Octapeptide Repeat Region Delays Bovine Spongiform Encephalopathy Pathogenesis in Mice.
    Hara H; Miyata H; Das NR; Chida J; Yoshimochi T; Uchiyama K; Watanabe H; Kondoh G; Yokoyama T; Sakaguchi S
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of Glycosaminoglycans Affects PrPSc Metabolism but Does Not Block PrPSc Uptake.
    Wolf H; Graßmann A; Bester R; Hossinger A; Möhl C; Paulsen L; Groschup MH; Schätzl H; Vorberg I
    J Virol; 2015 Oct; 89(19):9853-64. PubMed ID: 26202247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central residues in prion protein PrP
    Pasiana AD; Miyata H; Chida J; Hara H; Imamura M; Atarashi R; Sakaguchi S
    J Biol Chem; 2022 Sep; 298(9):102381. PubMed ID: 35973512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disulfide-crosslink scanning reveals prion-induced conformational changes and prion strain-specific structures of the pathological prion protein PrP
    Taguchi Y; Lu L; Marrero-Winkens C; Otaki H; Nishida N; Schatzl HM
    J Biol Chem; 2018 Aug; 293(33):12730-12740. PubMed ID: 29934306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glypican-1 mediates both prion protein lipid raft association and disease isoform formation.
    Taylor DR; Whitehouse IJ; Hooper NM
    PLoS Pathog; 2009 Nov; 5(11):e1000666. PubMed ID: 19936054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strain-Dependent Prion Infection in Mice Expressing Prion Protein with Deletion of Central Residues 91-106.
    Uchiyama K; Miyata H; Yamaguchi Y; Imamura M; Okazaki M; Pasiana AD; Chida J; Hara H; Atarashi R; Watanabe H; Kondoh G; Sakaguchi S
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational properties of prion strains can be transmitted to recombinant prion protein fibrils in real-time quaking-induced conversion.
    Sano K; Atarashi R; Ishibashi D; Nakagaki T; Satoh K; Nishida N
    J Virol; 2014 Oct; 88(20):11791-801. PubMed ID: 25078700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory response of microglia to prions is controlled by sialylation of PrP
    Srivastava S; Katorcha E; Makarava N; Barrett JP; Loane DJ; Baskakov IV
    Sci Rep; 2018 Jul; 8(1):11326. PubMed ID: 30054538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow Cytometric Detection of PrP
    Yamasaki T; Suzuki A; Hasebe R; Horiuchi M
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-prion Protein Antibody 6D11 Restores Cellular Proteostasis of Prion Protein Through Disrupting Recycling Propagation of PrP
    Pankiewicz JE; Sanchez S; Kirshenbaum K; Kascsak RB; Kascsak RJ; Sadowski MJ
    Mol Neurobiol; 2019 Mar; 56(3):2073-2091. PubMed ID: 29987703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Styryl-based and tricyclic compounds as potential anti-prion agents.
    Chung E; Prelli F; Dealler S; Lee WS; Chang YT; Wisniewski T
    PLoS One; 2011; 6(9):e24844. PubMed ID: 21931860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of rafts in the fibrillization and aggregation of prions.
    Pinheiro TJ
    Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of unglycosylated mutated prion protein facilitates PrP(Sc) formation in neuroblastoma cells infected with different prion strains.
    Korth C; Kaneko K; Prusiner SB
    J Gen Virol; 2000 Oct; 81(Pt 10):2555-2563. PubMed ID: 10993946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection.
    Marshall KE; Hughson A; Vascellari S; Priola SA; Sakudo A; Onodera T; Baron GS
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27847358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glypican-1 facilitates prion conversion in lipid rafts.
    Hooper NM
    J Neurochem; 2011 Mar; 116(5):721-5. PubMed ID: 20681952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the anti-prion mechanism of four different anti-prion compounds, anti-PrP monoclonal antibody 44B1, pentosan polysulfate, chlorpromazine, and U18666A, in prion-infected mouse neuroblastoma cells.
    Yamasaki T; Suzuki A; Hasebe R; Horiuchi M
    PLoS One; 2014; 9(9):e106516. PubMed ID: 25181483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Size and Stability of Infectious Prion Aggregates Fluctuate Dynamically during Cellular Uptake and Disaggregation.
    Shoup D; Priola SA
    Biochemistry; 2021 Feb; 60(5):398-411. PubMed ID: 33497187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An astrocyte cell line that differentially propagates murine prions.
    Tahir W; Abdulrahman B; Abdelaziz DH; Thapa S; Walia R; Schätzl HM
    J Biol Chem; 2020 Aug; 295(33):11572-11583. PubMed ID: 32561641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of lipid rafts in prion protein biology.
    Lewis V; Hooper NM
    Front Biosci (Landmark Ed); 2011 Jan; 16(1):151-68. PubMed ID: 21196164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.